Clinical Trial Update: IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of ilaprazole for treatment and prevention of peptic ulcer bleeding in Chinese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Bleeding

Drugs mentioned

• Ilaprazole (ilaprazole)

Snippet

Sponsor: Livzon Pharmaceutical Group Inc. | Conditions: Peptic Ulcer Hemorrhage | Phase 2 | Status: COMPLETED